Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Telix Pharmaceuticals Ltd (TLX.AX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in thousands)

	12-2024	12-2023	12-2022	12-2021	12-2020
Assets
Current Assets
Cash & Cash Equivalents	441,714	83,961	79,139	15,975	59,929
Receivables	98,867	44,133	26,773	14,078	9,533
Inventories	23,719	11,793	5,767	2,504	487
Other current assets	0	4,839	4,466	1,033	1,378
TOTAL	$571,189	$153,189	$117,850	$34,464	$71,987

Non-Current Assets
PPE Net	33,778	20,775	12,815	4,588	3,707
Investments And Advances	3,789	8,353	N/A	N/A	N/A
Intangibles	258,764	74,714	40,127	40,399	45,508
Other Non-Current Assets	75,440	14,333	2,924	154	141
TOTAL	$371,771	$118,174	$55,866	$45,140	$49,355

Total Assets	$942,960	$271,364	$173,717	$79,605	$121,342

Liabilities
Current Liabilities
Short Term Debt	11,809	657	N/A	14	203
Accounts payable and accrued liabilities	42,718	22,372	11,433	8,615	4,466
Accrued Expenses	33,181	N/A	N/A	N/A	N/A
Other current liabilities	53,421	7,491	3,361	4,453	4,835
TOTAL	$205,771	$107,242	$58,204	$27,534	$15,343

Non-Current Liabilities
Long Term Debt	343,138	5,593	2,253	N/A	73
Deferred Revenues	6,994	N/A	N/A	N/A	N/A
Other Non-Current Liabilities	27,780	51,845	54,414	49,124	44,139
TOTAL	$383,859	$62,668	$61,084	$50,507	$45,247

Total Liabilities	$589,629	$169,910	$119,288	$78,040	$60,590

Shareholders' Equity
Shares Outstanding, K	334,724	N/A	N/A	N/A	N/A
Common Shares	0	304,043	252,372	123,844	128,444
Retained earnings	-132,426	-179,635	-185,596	-125,751	-71,474
Other shareholders' equity	114,665	-22,954	-12,347	3,472	3,782
TOTAL	$353,331	$101,453	$54,429	$1,564	$60,752

Total Liabilities And Equity	$942,960	$271,364	$173,717	$79,605	$121,342